Dear member,

June 27, 2015

We have been blown away by the attention we’ve received from our warning on Kinder Morgan’s (KMI) valuation and dividend health. Our duty as an independent research provider has never been held in higher esteem as we outlined the prevalent hazards that reside both with sell-side research inundated with conflicts of interest and credit rating assessments that are paid for by the company. Independence will always trump biased analysis, and investors of all types have applauded us for this. We thank you. But being in the spotlight is nothing new for us. In the short history of the Dividend Cushion methodology, we have called in advance the dividend cuts on a few dozen equities: SeaDrill (SDRL), SuperValu (SVU), Roundy’s (RNDY),

Nike Is Just Too Pricey of a Stock

June 26, 2015

Everybody loves Nike, and that’s why its equity is trading at too high of a price. We think there are better values elsewhere.

Interest Rates: REITs vs. Financials

June 25, 2015

Since the peak of the Financial Crisis, the yield on the 10-year Treasury, a proxy for the risk-free rate within the valuation context, has been in a steady decline (see image above), but a strong bounce in rates since February continues to have the market on edge. Often moving in relation to Treasury yields are REITs and financial firms, though in opposite directions. Generally speaking, as interest rates rise, REITs experience selling pressure as investors opt for higher-yielding risk-free assets, while the opportunity to generate higher spread income is augmented with higher rates, sparking potential buying across the banking universe. The Fed continues to mull its options with how to build a “stimulus” cushion in advance of the next impending

Williams’ Rejection, Medtronic’s Hike, eBay’s Sale, and Hershey’s Disappointment

June 23, 2015

Williams Companies Rejects Offer from Energy Transfer Equity Natural gas pipeline company Williams Companies (WMB) has seen shares jump after Energy Transfer Equity (ETE) confirmed reports that it had made a bid to acquire the company. Despite the all-equity offer of $64 per share representing a 32% premium to Williams’ June 19 closing price, the offer was rejected by the firm as significantly too low. ETE has made multiple attempts to talk with Williams’ management about a possible merger in the past half year, and ETE has said its offer is contingent on the abortion of Williams’ pending purchase of Williams Partners (WPZ). The initial offer came on May 19, six days after Williams Companies announced it would buy Williams

Oracle’s Cloud Performance Leaves a Hazy Overall Outlook

June 22, 2015

After reporting fourth quarter and full year results for fiscal 2015 on June 17, Oracle (ORCL) shares took a significant hit. It is easy to see the effect foreign exchange rates had on the quarterly results, but there is more to the miss than meets the eye. In the fourth quarter of fiscal 2015, Oracle reported revenue of ~$10.7 billion, a decrease of 5% as reported, or an increase of 3% on a constant currency basis. Driving the top line lower was a decrease in software and cloud revenue, more specifically new software licenses, where sales dropped 17%; new software licenses make up more than 20% of total revenue. Attempting to offset this significant drop was strong 29% growth in

Dividend Increases for the Week Ending June 19

June 22, 2015

Below we provide a list of firms that raised their dividends during the week ending June 19. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports use the ‘Symbol’ search box in our website header. Firms Raising Their Dividends This Week Farmers & Merchants Bancorp (FMAO): now $0.22 per share quarterly dividend, was $0.21. FBR (FBRC): now $0.20 per share quarterly dividend, first dividend paid. First Bancorp (FNLC): now $0.22 per share quarterly dividend, was $0.21. Great Southern Bancorp (GSBC): now $0.22 per share quarterly dividend, was $0.20. Investar (ISTR): now $0.0078 per share quarterly dividend, was $0.0074. Medtronic (MDT): now $0.38 per share quarterly dividend, was

5 More Reasons Why We Think Kinder Morgan’s Shares Will Collapse

June 18, 2015

This article was originally published on valuentum.com/. “…the credit rating agencies have a lot to think about. Kinder Morgan’s investment-grade credit rating is in part supported by the firm’s ability to access the equity markets to sell its own stock. But its share price is artificially propped up by the incorrect application of dividend discount models that are using financially-engineered dividends, which themselves are in part supported by the debt raised from an investment-grade credit rating, which is then used to keep raising debt and growing the dividend…and so on.” 5 More Reasons Why We Think Kinder Morgan’s Shares Will Collapse It may feel like something’s different at our independent equity research firm, but nothing has changed in the past

Target-CVS Agreement: What It Really Means

June 16, 2015

Image Source: Mike Mozart Target (TGT) and CVS Health (CVS) announced an agreement June 15 in which CVS would acquire, rebrand, and operate Target’s pharmacies and clinics for the price of approximately $1.9 billion. After the deal closes, CVS will operate 1,660 of Target’s pharmacies in its stores under the CVS/pharmacy brand name. The nearly 80 Target clinics involved in the deal will be rebranded as MinuteClinic, and CVS plans to open up to 20 new clinics in Target stores, part of the CVS/minuteclinic goal to operate 1,500 clinics by 2017. Target and CVS also plan to open five to ten small, flexible store formats that will be branded TargetExpress and include a CVS/pharmacy. After Target’s recent Canada debacle, we

Business As Usual

June 15, 2015

It may seem like something is different, but nothing has changed since the last edition of the Best Ideas Newsletter. We’ll continue to provide spot-on analysis across our entire coverage universe. For some of our new members that may not be familiar with our independent investment research firm, we publish two newsletter portfolios. The Best Ideas Newsletter portfolio is housed in this publication, the Best Ideas Newsletter, which we release on the 15th of the month. The other newsletter portfolio that we produce is the Dividend Growth Newsletter portfolio, and that portfolio is housed in the Dividend Growth Newsletter, which we release on the 1st of each month. The newsletters are a companion to the research we produce on our website on

The Under-reported Story: The Presence of Avian Influenza May Be the “New Norm”

June 15, 2015

Source: Cal-Maine, Valuentum estimates; Urner-Barry Southeastern Regional Large Egg Market Price (per dozen eggs) Egg prices are soaring as the avian flu has run rampant across farms in Midwestern states. According to some studies, the outbreak has reduced the national flock by more than 10%, and it is the largest outbreak on record in US history. Egg prices are the highest they’ve been in some time, and investors may not be fully aware of the implications. A state of emergency has been declared in Iowa, where the impact may be the worst. Scientists believe the virus may recede as temperatures in the Midwest increase, but every company in the food products industry, big or small, is being impacted at the

Previous Next

About Our Name

But how, you will ask, does one decide what [stocks are] "attractive"? Most analysts feel they must choose between two approaches customarily thought to be in opposition: "value" and "growth,"...We view that as fuzzy thinking...Growth is always a component of value [and] the very term "value investing" is redundant.

                         -- Warren Buffett, Berkshire Hathaway annual report, 1992

At Valuentum, we take Buffett's thoughts one step further. We think the best opportunities arise from an understanding of a variety of investing disciplines in order to identify the most attractive stocks at any given time. Valuentum therefore analyzes each stock across a wide spectrum of philosophies, from deep value through momentum investing. And a combination of the two approaches found on each side of the spectrum (value/momentum) in a name couldn't be more representative of what our analysts do here; hence, we're called Valuentum.



The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Valuentum Exclusive publication, ESG Newsletter, and any reports, data and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, data or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor, and does not offer brokerage or investment banking services. The sources of the data used on this website and reports are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum, its employees, and independent contractors may have long, short or derivative positions in the securities mentioned on this website. The High Yield Dividend Newsletter portfolio, ESG Newsletter portfolio, Best Ideas Newsletter portfolio and Dividend Growth Newsletter portfolio are not real money portfolios. Performance, including that in the Valuentum Exclusive publication and additional options commentary feature, is hypothetical and does not represent actual trading. Actual results may differ from simulated information, results, or performance being presented. For more information about Valuentum and the products and services it offers, please contact us at info@valuentum.com.